What is Epicrop Technologies?
Epicrop Technologies operates at the intersection of computational science and plant biology, specializing in epigenetic crop breeding. Unlike traditional genetic modification, the company utilizes nature-based approaches to unlock latent genetic potential within existing plant varieties. This proprietary technology enhances critical traits such as heat resistance, cold tolerance, and overall yield, providing a robust solution for agricultural sectors grappling with the volatility of climate change.
With over a decade of rigorous field testing, the company has established a unique market position. By focusing on non-GMO, epigenetic-driven improvements, Epicrop Technologies offers a sustainable alternative that aligns with evolving regulatory landscapes and consumer preferences for environmentally conscious agricultural practices. Their platform is designed to optimize crop selection, ensuring that farmers can maintain productivity despite increasingly adverse environmental conditions.
How much funding has Epicrop Technologies raised?
Epicrop Technologies has raised a total of $3.3M across 2 funding rounds:
Series A
$3.2M
Debt
$116K
Series A (2017): $3.2M with participation from Allen & Company, Speedway Properties, Nelnet, Inc., and TechAccel
Debt (2021): $116K led by PPP
Key Investors in Epicrop Technologies
TechAccel
TechAccel is a hybrid venture development organization that bridges the innovation gap between discovery and commercialization in agriculture, animal health, and food technology.
Nelnet, Inc.
Nelnet is a diversified financial services and technology company providing payment solutions, student loan servicing, and telecommunications infrastructure.
Speedway Properties
Speedway Properties is a real estate development firm focused on commercial and residential infrastructure, contributing to regional economic growth in the Midwest.
What's next for Epicrop Technologies?
With the recent influx of capital, Epicrop Technologies is set to accelerate its commercialization roadmap. The strategic focus will likely shift toward expanding its footprint in key agricultural markets and scaling its computational breeding platform to accommodate a broader range of crop varieties. As the company moves beyond the development phase, the emphasis will be on establishing strategic partnerships with global agribusinesses to integrate their epigenetic solutions into existing supply chains.
Furthermore, the company is expected to leverage its recent financing to bolster its research and development infrastructure, ensuring that its technology remains at the forefront of the ag-tech sector. By maintaining its commitment to non-GMO innovation, Epicrop Technologies is well-positioned to capture significant market share as the industry pivots toward more sustainable and resilient farming practices.
